Evidence map›Paper›PMID 32944345›Full record

ArticleJournal of thoracic disease2020

The impact of concordance with a lung cancer diagnosis pathway guideline on treatment access in patients with stage IV lung cancer.

Andrew Pattison, Luke Jeagal, Kazuhiro Yasufuku, Andrew Pierre, Laura Donahoe, Jonathan Yeung, Gail Darling, Marcelo Cypel, Marc De Perrot, Tom Waddell and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of thoracic disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Andrew PattisonDivision of Thoracic Surgery, Toronto General Hospital, University Health Network, University of Toronto, Ontario, Canada.
Luke JeagalDivision of Respirology, Toronto General Hospital, University Health Network, University of Toronto, Ontario, Canada.
Kazuhiro YasufukuDivision of Thoracic Surgery, Toronto General Hospital, University Health Network, University of Toronto, Ontario, Canada.
Andrew PierreDivision of Thoracic Surgery, Toronto General Hospital, University Health Network, University of Toronto, Ontario, Canada.
Laura DonahoeDivision of Thoracic Surgery, Toronto General Hospital, University Health Network, University of Toronto, Ontario, Canada.
Jonathan YeungDivision of Thoracic Surgery, Toronto General Hospital, University Health Network, University of Toronto, Ontario, Canada.
Gail DarlingDivision of Thoracic Surgery, Toronto General Hospital, University Health Network, University of Toronto, Ontario, Canada.
Marcelo CypelDivision of Thoracic Surgery, Toronto General Hospital, University Health Network, University of Toronto, Ontario, Canada.
Marc De PerrotDivision of Thoracic Surgery, Toronto General Hospital, University Health Network, University of Toronto, Ontario, Canada.
Tom WaddellDivision of Thoracic Surgery, Toronto General Hospital, University Health Network, University of Toronto, Ontario, Canada.
Shaf KeshavjeeDivision of Thoracic Surgery, Toronto General Hospital, University Health Network, University of Toronto, Ontario, Canada.
Kasia Czarnecka-KujawaDivision of Thoracic Surgery, Toronto General Hospital, University Health Network, University of Toronto, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTimely access to treatment of lung cancer is dependent on efficient and appropriate patient assessment and early referral for diagnostic workup. This study assesses the impact of Cancer Care Ontario (CCO) Lung Cancer Diagnostic Pathway Guideline (LCDPG) concordance on access to treatment of stage IV lung cancer patients referred to the Diagnostic Assessment Program (DAP) at a Canadian tertiary cancer centre.

methodsThis retrospective cohort study includes patients diagnosed with clinical stage IV lung cancer referred to the DAP at a Canadian tertiary cancer centre between November 1, 2015 and May 31, 2017. Referral concordance was determined based on CCO LCDPG. The primary outcome; time to treatment from initial healthcare presentation; was compared between the concordant and discordant referrals.

resultsTwo hundred patients were referred for clinical stage IV lung cancer during the study period. Of these referrals, 151 (75.5%) were assessed and referred in concordance with LCDPG. Guideline concordant referrals were associated with reduced time to treatment from first healthcare presentation compared with guideline discordant referrals (55.3

conclusionsGuideline concordant assessment and referral of stage IV lung cancer patients results in reduced time to diagnosis and treatment. Future research and education should focus on improving factors that delay DAP referral.

Indexed as

concordancediagnostic pathwayLung cancer

Identifiers

PMID32944345
PMCPMC7475595

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.